248 related articles for article (PubMed ID: 37629053)
1. Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis.
Gernert JA; Böhm L; Starck M; Buchka S; Kümpfel T; Kleiter I; Havla J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629053
[TBL] [Abstract][Full Text] [Related]
2. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
[TBL] [Abstract][Full Text] [Related]
3. Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy.
Sotirchos ES; Gonzalez Caldito N; Filippatou A; Fitzgerald KC; Murphy OC; Lambe J; Nguyen J; Button J; Ogbuokiri E; Crainiceanu CM; Prince JL; Calabresi PA; Saidha S;
Ann Neurol; 2020 Jun; 87(6):885-896. PubMed ID: 32285484
[TBL] [Abstract][Full Text] [Related]
4. Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis.
Miscioscia A; Puthenparampil M; Miante S; Pengo M; Rinaldi F; Perini P; Gallo P
J Neurol; 2022 Oct; 269(10):5436-5442. PubMed ID: 35648233
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
Behbehani R; Abu Al-Hassan A; Al-Salahat A; Sriraman D; Oakley JD; Alroughani R
PLoS One; 2017; 12(2):e0172120. PubMed ID: 28192539
[TBL] [Abstract][Full Text] [Related]
6. Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post Hoc Analyses of the SPRINT-MS Trial.
Ehrhardt H; Lambe J; Moussa H; Vasileiou ES; Kalaitzidis G; Murphy OC; Filippatou AG; Pellegrini N; Douglas M; Davis S; Nagy N; Quiroga A; Hu C; Zambriczki Lee A; Duval A; Fitzgerald KC; Prince JL; Calabresi PA; Sotirchos ES; Bermel R; Saidha S
Neurology; 2023 Sep; 101(10):e1014-e1024. PubMed ID: 37460235
[TBL] [Abstract][Full Text] [Related]
7. Retinal nerve fiber and ganglion cell complex layer thicknesses mirror brain atrophy in patients with relapsing-remitting multiple sclerosis.
Glasner P; Sabisz A; Chylińska M; Komendziński J; Wyszomirski A; Karaszewski B
Restor Neurol Neurosci; 2022; 40(1):35-42. PubMed ID: 35180139
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography (OCT) measurements and disability in multiple sclerosis (MS): A systematic review and meta-analysis.
Mirmosayyeb O; Yazdan Panah M; Mokary Y; Ghaffary EM; Ghoshouni H; Zivadinov R; Weinstock-Guttman B; Jakimovski D
J Neurol Sci; 2023 Nov; 454():120847. PubMed ID: 37924591
[TBL] [Abstract][Full Text] [Related]
9. Rate of Retinal Layer Thinning as a Biomarker for Conversion to Progressive Disease in Multiple Sclerosis.
El Ayoubi NK; Sabbagh HM; Bou Rjeily N; Hannoun S; Khoury SJ
Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36229190
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study.
Paul F; Calabresi PA; Barkhof F; Green AJ; Kardon R; Sastre-Garriga J; Schippling S; Vermersch P; Saidha S; Gerendas BS; Schmidt-Erfurth U; Agoropoulou C; Zhang Y; Seifer G; Petzold A
Ann Clin Transl Neurol; 2021 Dec; 8(12):2235-2251. PubMed ID: 34792863
[TBL] [Abstract][Full Text] [Related]
11. Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis.
Berek K; Hegen H; Hocher J; Auer M; Di Pauli F; Krajnc N; Angermann R; Barket R; Zinganell A; Riedl K; Deisenhammer F; Berger T; Bsteh G
Mult Scler; 2022 Oct; 28(12):1871-1880. PubMed ID: 35652366
[TBL] [Abstract][Full Text] [Related]
12. Choroid plexus volume as a marker of retinal atrophy in relapsing remitting multiple sclerosis.
Raghib MF; Bao F; Elkhooly M; Bernitsas E
J Neurol Sci; 2024 Feb; 457():122884. PubMed ID: 38237367
[TBL] [Abstract][Full Text] [Related]
13. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
[TBL] [Abstract][Full Text] [Related]
14. Identifying Optical Coherence Tomography Markers for Multiple Sclerosis Diagnosis and Management.
Cujba L; Stan C; Samoila O; Drugan T; Benedec Cutas A; Nicula C
Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370972
[TBL] [Abstract][Full Text] [Related]
15. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
Saidha S; Sotirchos ES; Ibrahim MA; Crainiceanu CM; Gelfand JM; Sepah YJ; Ratchford JN; Oh J; Seigo MA; Newsome SD; Balcer LJ; Frohman EM; Green AJ; Nguyen QD; Calabresi PA
Lancet Neurol; 2012 Nov; 11(11):963-72. PubMed ID: 23041237
[TBL] [Abstract][Full Text] [Related]
16. Retinal thickness as a potential biomarker of neurodegeneration and a predictor of early cognitive impairment in patients with multiple sclerosis.
Esmael A; Elsherif M; Abdelsalam M; Sabry D; Mamdouh M; Belal T
Neurol Res; 2020 Jul; 42(7):564-574. PubMed ID: 32370626
[TBL] [Abstract][Full Text] [Related]
17. Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
Sotirchos ES; Vasileiou ES; Filippatou AG; Fitzgerald KC; Smith MD; Lord HN; Kalaitzidis G; Lambe J; Duval A; Prince JL; Mowry EM; Saidha S; Calabresi PA
Neurology; 2022 Aug; 99(7):e688-e697. PubMed ID: 35618438
[TBL] [Abstract][Full Text] [Related]
18. Retinal imaging and axonal degeneration in later onset multiple sclerosis.
Huhn K; Lämmer R; Zimmermann H; Lämmer A; Waschbisch A; Utz K; Gieß RM; Paul F; Linker RA; Lee DH
J Neurol Sci; 2016 Nov; 370():1-6. PubMed ID: 27772735
[TBL] [Abstract][Full Text] [Related]
19. Inner and outer retina findings determined by optical coherence tomography in different subtypes of multiple sclerosis.
Yurtogullari S; Erbahceci IE
Niger J Clin Pract; 2022 Jul; 25(7):1069-1075. PubMed ID: 35859467
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients.
Chan JK; Hernandez Martínez de Lapiscina E; Taylor C; Nguyen AL; Alba-Arbalat S; Devonshire V; Sayao AL; Carruthers R; Costello F; Traboulsee A
J Neuroophthalmol; 2020 Mar; 40(1):37-43. PubMed ID: 32045393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
